First Header Logo Second Header Logo

Connection

Karen Haas to Mice

This is a "connection" page, showing publications Karen Haas has written about Mice.
Connection Strength

1.870
  1. Daly CA, Spurrier MA, Jennings-Gee JE, Haas KM. B Cell Subsets Differentially Contribute to the T Cell-Independent Memory Pool. J Immunol. 2020 11 01; 205(9):2362-2374.
    View in: PubMed
    Score: 0.119
  2. Dyevoich AM, Disher NS, Haro MA, Haas KM. A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells. Cancer Immunol Immunother. 2020 Oct; 69(10):2113-2124.
    View in: PubMed
    Score: 0.116
  3. Dyevoich AM, Haas KM. Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination. Mol Cancer Ther. 2020 06; 19(6):1232-1242.
    View in: PubMed
    Score: 0.114
  4. Phipps JP, Haas KM. An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses. J Infect Dis. 2019 01 07; 219(2):323-334.
    View in: PubMed
    Score: 0.105
  5. Haro MA, Dyevoich AM, Phipps JP, Haas KM. Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity. Cancer Res. 2019 01 01; 79(1):159-170.
    View in: PubMed
    Score: 0.103
  6. Haas KM, Johnson KL, Phipps JP, Do C. CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens. J Immunol. 2018 03 01; 200(5):1671-1681.
    View in: PubMed
    Score: 0.099
  7. McKay JT, Haro MA, Daly CA, Yammani RD, Pang B, Swords WE, Haas KM. PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism. J Immunol. 2017 09 15; 199(6):2020-2029.
    View in: PubMed
    Score: 0.095
  8. Haas KM. B-1 lymphocytes in mice and nonhuman primates. Ann N Y Acad Sci. 2015 Dec; 1362:98-109.
    View in: PubMed
    Score: 0.082
  9. McKay JT, Egan RP, Yammani RD, Chen L, Shin T, Yagita H, Haas KM. PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism. J Immunol. 2015 Mar 01; 194(5):2289-99.
    View in: PubMed
    Score: 0.080
  10. Yammani RD, Leyva MA, Jennings RN, Haas KM. C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. J Immunol. 2014 Dec 01; 193(11):5434-43.
    View in: PubMed
    Score: 0.079
  11. Haas KM, Blevins MW, High KP, Pang B, Swords WE, Yammani RD. Aging promotes B-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: implications for vaccine protection in older adults. J Infect Dis. 2014 Jan 01; 209(1):87-97.
    View in: PubMed
    Score: 0.073
  12. Yammani RD, Haas KM. Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens. J Immunol. 2013 Apr 01; 190(7):3100-8.
    View in: PubMed
    Score: 0.070
  13. Haas KM. Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens. J Immunol. 2011 Nov 15; 187(10):5183-95.
    View in: PubMed
    Score: 0.064
  14. Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, Okochi H, Fujimoto M, Tedder TF. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol. 2010 May 01; 184(9):4789-800.
    View in: PubMed
    Score: 0.057
  15. Haas KM, Poe JC, Tedder TF. CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression. J Immunol. 2009 Sep 15; 183(6):3661-71.
    View in: PubMed
    Score: 0.055
  16. Haas KM, Sen S, Sanford IG, Miller AS, Poe JC, Tedder TF. CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo. J Immunol. 2006 Sep 01; 177(5):3063-73.
    View in: PubMed
    Score: 0.045
  17. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity. 2005 Jul; 23(1):7-18.
    View in: PubMed
    Score: 0.041
  18. Haas KM, Tedder TF. Role of the CD19 and CD21/35 receptor complex in innate immunity, host defense and autoimmunity. Adv Exp Med Biol. 2005; 560:125-39.
    View in: PubMed
    Score: 0.040
  19. Tedder TF, Poe JC, Haas KM. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction. Adv Immunol. 2005; 88:1-50.
    View in: PubMed
    Score: 0.040
  20. Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J Immunol. 2004 May 15; 172(10):5833-7.
    View in: PubMed
    Score: 0.038
  21. Uchida J, Lee Y, Hasegawa M, Liang Y, Bradney A, Oliver JA, Bowen K, Steeber DA, Haas KM, Poe JC, Tedder TF. Mouse CD20 expression and function. Int Immunol. 2004 Jan; 16(1):119-29.
    View in: PubMed
    Score: 0.037
  22. Haas KM, Hasegawa M, Steeber DA, Poe JC, Zabel MD, Bock CB, Karp DR, Briles DE, Weis JH, Tedder TF. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity. 2002 Dec; 17(6):713-23.
    View in: PubMed
    Score: 0.035
  23. Haas KM, Taylor KA, MacHugh ND, Kreeger JM, Estes DM. Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection. J Leukoc Biol. 2001 Dec; 70(6):931-40.
    View in: PubMed
    Score: 0.032
  24. Haas KM, Estes DM. The identification and characterization of a ligand for bovine CD5. J Immunol. 2001 Mar 01; 166(5):3158-66.
    View in: PubMed
    Score: 0.031
  25. Crump KE, Juneau DG, Poole LB, Haas KM, Grayson JM. The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation. Eur J Immunol. 2012 Aug; 42(8):2152-64.
    View in: PubMed
    Score: 0.017
  26. Poe JC, Minard-Colin V, Kountikov EI, Haas KM, Tedder TF. A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice. J Immunol. 2012 Sep 01; 189(5):2318-25.
    View in: PubMed
    Score: 0.017
  27. Tracy ET, Haas KM, Gentry T, Danko M, Roberts JL, Kurtzberg J, Rice HE. Partial splenectomy but not total splenectomy preserves immunoglobulin M memory B cells in mice. J Pediatr Surg. 2011 Sep; 46(9):1706-10.
    View in: PubMed
    Score: 0.016
  28. Poe JC, Smith SH, Haas KM, Yanaba K, Tsubata T, Matsushita T, Tedder TF. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One. 2011; 6(7):e22464.
    View in: PubMed
    Score: 0.016
  29. Smith SH, Haas KM, Poe JC, Yanaba K, Ward CD, Migone TS, Tedder TF. B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals. Int Immunol. 2010 Aug; 22(8):681-91.
    View in: PubMed
    Score: 0.015
  30. Minard-Colin V, Xiu Y, Poe JC, Horikawa M, Magro CM, Hamaguchi Y, Haas KM, Tedder TF. Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV. Blood. 2008 Aug 15; 112(4):1205-13.
    View in: PubMed
    Score: 0.013
  31. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008 May; 28(5):639-50.
    View in: PubMed
    Score: 0.013
  32. DiLillo DJ, Hamaguchi Y, Ueda Y, Yang K, Uchida J, Haas KM, Kelsoe G, Tedder TF. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol. 2008 Jan 01; 180(1):361-71.
    View in: PubMed
    Score: 0.012
  33. Zabel MD, Heikenwalder M, Prinz M, Arrighi I, Schwarz P, Kranich J, von Teichman A, Haas KM, Zeller N, Tedder TF, Weis JH, Aguzzi A. Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. J Immunol. 2007 Nov 01; 179(9):6144-52.
    View in: PubMed
    Score: 0.012
  34. Ford JW, Kilmon MA, Haas KM, Shelburne AE, Chan-Li Y, Conrad DH. In vivo murine CD23 destabilization enhances CD23 shedding and IgE synthesis. Cell Immunol. 2006 Oct; 243(2):107-17.
    View in: PubMed
    Score: 0.012
  35. Pongratz G, McAlees JW, Conrad DH, Erbe RS, Haas KM, Sanders VM. The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner. J Immunol. 2006 Sep 01; 177(5):2926-38.
    View in: PubMed
    Score: 0.011
  36. Lee Y, Haas KM, Gor DO, Ding X, Karp DR, Greenspan NS, Poe JC, Tedder TF. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement. J Immunol. 2005 Dec 15; 175(12):8011-23.
    View in: PubMed
    Score: 0.011
  37. Hamaguchi Y, Uchida J, Cain DW, Venturi GM, Poe JC, Haas KM, Tedder TF. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J Immunol. 2005 Apr 01; 174(7):4389-99.
    View in: PubMed
    Score: 0.010
  38. Tedder TF, Poe JC, Fujimoto M, Haas KM, Sato S. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr Dir Autoimmun. 2005; 8:55-90.
    View in: PubMed
    Score: 0.010
  39. Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, Sanford IG, Bock CB, Fujimoto M, Tedder TF. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol. 2004 Oct; 5(10):1078-87.
    View in: PubMed
    Score: 0.010
  40. Uchida J, Hamaguchi Y, Oliver JA, Ravetch JV, Poe JC, Haas KM, Tedder TF. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med. 2004 Jun 21; 199(12):1659-69.
    View in: PubMed
    Score: 0.010
  41. Poe JC, Haas KM, Uchida J, Lee Y, Fujimoto M, Tedder TF. Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background. J Immunol. 2004 Feb 15; 172(4):2100-10.
    View in: PubMed
    Score: 0.009
  42. Austin AS, Haas KM, Naugler SM, Bajer AA, Garcia-Tapia D, Estes DM. Identification and characterization of a novel regulatory factor: IgA-inducing protein. J Immunol. 2003 Aug 01; 171(3):1336-42.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.